Cargando…
HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR Assay for Detecting High-Grade Cervical Lesion with Microscope Slides
After breast and colon cancer, cervical cancer is the third most common cancer of women worldwide. Since human papillomavirus (HPV) infection is known to be the predominant cause of cervical cancer, molecular HPV screening is currently used along with cytological and histological examination methods...
Autores principales: | Kim, Geehyuk, Taye, Jemberu, Yu, Kwangmin, Park, Sunyoung, Kim, Jungho, Kim, Sunghyun, Lee, Dongsup, Wang, Hye-young, Park, Kwang Hwa, Lee, Hyeyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350568/ https://www.ncbi.nlm.nih.gov/pubmed/30775237 http://dx.doi.org/10.1155/2019/9365654 |
Ejemplares similares
-
MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer
por: Park, Sunyoung, et al.
Publicado: (2017) -
microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer
por: Park, Sunyoung, et al.
Publicado: (2019) -
ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis
por: Park, Sunyoung, et al.
Publicado: (2019) -
Correction: ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis
por: Park, Sunyoung, et al.
Publicado: (2019) -
Promotion of tumorigenesis by miR‐1260b–targeting CASP8: Potential diagnostic and prognostic marker for breast cancer
por: Park, Sunyoung, et al.
Publicado: (2022)